Consensus $8.71. Raises FY23 revenue view to $9.19B-$9.24B from $9.12B-$9.22B, consensus $9.18B. Sees FY23 capital expenditures $400M. Sees FY23 cash provided by operations $1.3B.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DGX:
- Quest Diagnostics Reports Third Quarter 2023 Financial Results; Updates Guidance for Full Year 2023
- Notable companies reporting before tomorrow’s open
- Quest Diagnostics (DGX) Q3 Earnings Cheat Sheet
- Quest Diagnostics price target lowered to $130 from $145 at Piper Sandler
- Quest Diagnostics price target lowered to $130 from $136 at Evercore ISI